{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,28]],"date-time":"2025-12-28T12:26:36Z","timestamp":1766924796294,"version":"3.48.0"},"reference-count":98,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T00:00:00Z","timestamp":1747094400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T00:00:00Z","timestamp":1747094400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11033-025-10558-4","type":"journal-article","created":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T05:57:14Z","timestamp":1747115834000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Clinical aspect of male breast cancer: a burgeoning and unaddressed issue"],"prefix":"10.1007","volume":"52","author":[{"given":"Suman Kumar","family":"Ray","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sukhes","family":"Mukherjee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,13]]},"reference":[{"issue":"7","key":"10558_CR1","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1634\/theoncologist.10-7-471","volume":"10","author":"SH Giordano","year":"2005","unstructured":"Giordano SH (2005) A review of the diagnosis and management of male breast cancer. Oncologist 10(7):471\u2013479","journal-title":"Oncologist"},{"issue":"5","key":"10558_CR2","first-page":"365","volume":"49","author":"Y Erhan","year":"2006","unstructured":"Erhan Y, Zekioglu O, Erhan Y (2006) Invasive lobular carcinoma of the male breast. Can J Surg 49(5):365\u2013366","journal-title":"Can J Surg"},{"issue":"3","key":"10558_CR3","doi-asserted-by":"crossref","first-page":"158","DOI":"10.5603\/OCP.2023.0008","volume":"19","author":"A Soni","year":"2023","unstructured":"Soni A, Paul D, Verma M, Kaur P, Chauhan A, Kaushal V (2023) Male breast cancer: a budding and unaddressed issue. Oncol Clin Pract 19(3):158\u2013166","journal-title":"Oncol Clin Pract"},{"issue":"2","key":"10558_CR4","doi-asserted-by":"crossref","first-page":"010","DOI":"10.30574\/wjarr.2023.17.2.0190","volume":"17","author":"J Daniels","year":"2023","unstructured":"Daniels J, Aduse-Poku AY, Gawu P (2023) Overview of male breast cancer. World J Adv Res Rev 17(2):010\u2013022","journal-title":"World J Adv Res Rev"},{"issue":"3","key":"10558_CR5","doi-asserted-by":"crossref","first-page":"506","DOI":"10.5534\/wjmh.200164","volume":"39","author":"EB Elimimian","year":"2021","unstructured":"Elimimian EB et al (2021) Male breast cancer: a comparative analysis from the national cancer database. World J Mens Health 39(3):506\u2013515","journal-title":"World J Mens Health"},{"issue":"2","key":"10558_CR6","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.critrevonc.2009.04.003","volume":"73","author":"L Ottini","year":"2010","unstructured":"Ottini L, Palli D, Rizzo S, Federico M, Bazan V, Russo A (2010) Male breast cancer. Crit Rev Oncol Hematol 73(2):141\u2013155","journal-title":"Crit Rev Oncol Hematol"},{"key":"10558_CR7","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0140-6736(06)68226-3","volume":"367","author":"IS Fentiman","year":"2006","unstructured":"Fentiman IS, Fourquet A, Hortobagyi GN (2006) Male breast cancer. Lancet 367:595\u2013604","journal-title":"Lancet"},{"key":"10558_CR8","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1158\/1055-9965.20.14.1","volume":"14","author":"JR Weiss","year":"2005","unstructured":"Weiss JR, Moysich KB, Swede H (2005) Epidemiology of male breast cancer. Cancer Epidemiol Biomarkers Prev 14:20\u201326","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10558_CR9","doi-asserted-by":"crossref","first-page":"678","DOI":"10.7326\/0003-4819-137-8-200210150-00013","volume":"137","author":"SH Giordano","year":"2002","unstructured":"Giordano SH, Buzdar AU, Hortobagyi GN (2002) Breast cancer in men. Ann Intern Med 137:678\u2013687","journal-title":"Ann Intern Med"},{"key":"10558_CR10","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1002\/ijc.2910530403","volume":"53","author":"AJ Sasco","year":"1993","unstructured":"Sasco AJ, Lowenfels AB, Pasker-de Jong P (1993) Review article: epidemiology of male breast cancer. A meta-analysis of published case\u2013control studies and discussion of selected aetiological factors. Int J Cancer 53:538\u2013549","journal-title":"Int J Cancer"},{"key":"10558_CR11","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1002\/cncr.10521","volume":"94","author":"CD O\u2019Malley","year":"2002","unstructured":"O\u2019Malley CD, Prehn AW, Shema SJ, Glaser SL (2002) Racial\/ethnic differences in survival rates in a population-based series of men with breast carcinoma. Cancer 94:2836\u20132843","journal-title":"Cancer"},{"key":"10558_CR12","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1016\/j.ejca.2004.07.012","volume":"40","author":"D Palli","year":"2004","unstructured":"Palli D, Masala G, Mariani-Costantini R et al (2004) A gene-environment interaction between occupation and BRCA1\/BRCA2 mutations in male breast cancer? Eur J Cancer 40:2474\u20132479","journal-title":"Eur J Cancer"},{"key":"10558_CR13","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1093\/oxfordjournals.aje.a116360","volume":"135","author":"DB Thomas","year":"1992","unstructured":"Thomas DB, Jimenez LM, McTiernan A et al (1992) Breast cancer in men: risk factors with hormonal implications. Am J Epidemiol 135:734\u2013748","journal-title":"Am J Epidemiol"},{"key":"10558_CR14","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1572-0241.1998.00231.x","volume":"93","author":"HT Sorensen","year":"1998","unstructured":"Sorensen HT, Friis S, Olsen JH et al (1998) Risk of breast cancer in men with liver cirrhosis. Am J Gastroenterol 93:231\u2013233","journal-title":"Am J Gastroenterol"},{"key":"10558_CR15","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1038\/bjc.1995.264","volume":"71","author":"B D\u2019Avanzo","year":"1995","unstructured":"D\u2019Avanzo B, La Vecchia C (1995) Risk factors for male breast cancer. Br J Cancer 71:1359\u20131362","journal-title":"Br J Cancer"},{"key":"10558_CR16","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/00008469-200504000-00016","volume":"14","author":"HT Sorensen","year":"2005","unstructured":"Sorensen HT, Olsen ML, Mellemkjaer L et al (2005) The intrauterine origin of male breast cancer: a birth order study in Denmark. Eur J Cancer Prev 14:185\u2013186","journal-title":"Eur J Cancer Prev"},{"key":"10558_CR17","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1097\/01.SMJ.0000050686.54786.79","volume":"97","author":"K Coard","year":"2004","unstructured":"Coard K, McCartney T (2004) Bilateral synchronous carcinoma of the male breast in a patient receiving estrogen therapy for carcinoma of the prostate: cause or coincidence? South Med J 97:308\u2013310","journal-title":"South Med J"},{"key":"10558_CR18","first-page":"1077","volume":"24","author":"P Karamanakos","year":"2004","unstructured":"Karamanakos P, Mitsiades CS, Lembessis P et al (2004) Male breast adenocarcinoma in a prostate cancer patient following prolonged anti-androgen monotherapy. Anticancer Res 24:1077\u20131081","journal-title":"Anticancer Res"},{"key":"10558_CR19","first-page":"758","volume":"50","author":"P Guenel","year":"1993","unstructured":"Guenel P, Raskmark P, Andersen JB, Lynge E (1993) Incidence of cancer in persons with occupational exposure to electromagnetic fields in Denmark. Br J Ind Med 50:758\u2013764","journal-title":"Br J Ind Med"},{"key":"10558_CR20","first-page":"9","volume":"5","author":"DB Thomas","year":"1994","unstructured":"Thomas DB, Rosenblatt K, Jimenez LM et al (1994) Ionizing radiation and breast cancer in men (United States). Cancer Causes Control 5:9\u201314","journal-title":"Cancer Causes Control"},{"key":"10558_CR21","first-page":"371","volume":"74","author":"K Mabuchi","year":"1985","unstructured":"Mabuchi K, Bross DS, Kessler II (1985) Risk factors for male breast cancer. J Natl Cancer Inst 74:371\u2013375","journal-title":"J Natl Cancer Inst"},{"key":"10558_CR22","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1080\/028418601750288181","volume":"40","author":"M Ewertz","year":"2001","unstructured":"Ewertz M, Holmberg L, Tretli S et al (2001) Risk factors for male breast cancer\u2014a case\u2013control study from Scandinavia. Acta Oncol 40:467\u2013471","journal-title":"Acta Oncol"},{"key":"10558_CR23","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/00008469-200206000-00009","volume":"11","author":"KC Johnson","year":"2002","unstructured":"Johnson KC, Pan S, Mao Y (2002) Risk factors for male breast cancer in Canada, 1994\u20131998. Eur J Cancer Prev 11:253\u2013263","journal-title":"Eur J Cancer Prev"},{"key":"10558_CR24","doi-asserted-by":"crossref","first-page":"R2","DOI":"10.1186\/bcr419","volume":"4","author":"VM Basham","year":"2002","unstructured":"Basham VM, Lipscombe JM, Ward JM et al (2002) BRCA1 and BRCA2 mutations in a population-based study of male breast cancer. Breast Cancer Res 4:R2","journal-title":"Breast Cancer Res"},{"key":"10558_CR25","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/1471-2407-7-170","volume":"7","author":"D Palli","year":"2007","unstructured":"Palli D, Falchetti M, Masala G et al (2007) Association between the BRCA2 N372H variant and male breast cancer risk: a populationbased case\u2013control study in Tuscany Central Italy. BMC Cancer 7:170","journal-title":"BMC Cancer"},{"key":"10558_CR26","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/ijc.2910450415","volume":"45","author":"MH Lenfant-Pejovic","year":"1990","unstructured":"Lenfant-Pejovic MH, Mlika-Cabanne N, Bouchardy C, Auquier A (1990) Risk factors for male breast cancer: a Franco-Swiss case\u2013control study. Int J Cancer 45:661\u2013665","journal-title":"Int J Cancer"},{"issue":"Suppl 1","key":"10558_CR27","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1186\/bcr1643","volume":"9","author":"S Satram-Hoang","year":"2007","unstructured":"Satram-Hoang S, Ziogas A, Anton-Culver H (2007) Risk of second primary cancer in men with breast cancer. Breast Cancer Res 9(Suppl 1):S10","journal-title":"Breast Cancer Res"},{"key":"10558_CR28","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1093\/jnci\/94.17.1330","volume":"94","author":"A Auvinen","year":"2002","unstructured":"Auvinen A, Curtis RE, Ron E (2002) Risk of subsequent cancer following breast cancer in men. J Natl Cancer Inst 94:1330\u20131332","journal-title":"J Natl Cancer Inst"},{"key":"10558_CR29","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1200\/JCO.1995.13.7.1578","volume":"13","author":"P Broet","year":"1995","unstructured":"Broet P, de la Rochefordiere A, Scholl SM et al (1995) Contralateral breast cancer: annual incidence and risk parameters. J Clin Oncol 13:1578\u20131583","journal-title":"J Clin Oncol"},{"key":"10558_CR30","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1086\/301749","volume":"62","author":"D Ford","year":"1998","unstructured":"Ford D, Easton DF, Stratton M et al (1998) Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The breast cancer linkage consortium. Am J Hum Genet 62:676\u2013689","journal-title":"Am J Hum Genet"},{"key":"10558_CR31","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1200\/JCO.2002.20.6.1480","volume":"20","author":"TS Frank","year":"2002","unstructured":"Frank TS, Deffenbaugh AM, Reid JE et al (2002) Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals. J Clin Oncol 20:1480\u20131490","journal-title":"J Clin Oncol"},{"key":"10558_CR32","first-page":"1079","volume":"60","author":"S Thorlacius","year":"1997","unstructured":"Thorlacius S, Sigurdsson S, Bjarnadottir H et al (1997) Study of a single BRCA2 mutation with high carrier frequency in a small population. Am J Hum Genet 60:1079\u20131084","journal-title":"Am J Hum Genet"},{"key":"10558_CR33","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s10689-007-9153-9","volume":"7","author":"DG Evans","year":"2008","unstructured":"Evans DG, Bulman M, Young K et al (2008) BRCA1\/2 mutation analysis in male breast cancer families from North West England. Fam Cancer 7:113\u2013117","journal-title":"Fam Cancer"},{"key":"10558_CR34","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/1471-2407-6-156","volume":"6","author":"G Miolo","year":"2006","unstructured":"Miolo G, Puppa LD, Santarosa M et al (2006) Phenotypic features and genetic characterization of male breast cancer families: identification of two recurrent BRCA2 mutations in north-east of Italy. BMC Cancer 6:156","journal-title":"BMC Cancer"},{"key":"10558_CR35","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/ng879","volume":"31","author":"H Meijers-Heijboer","year":"2002","unstructured":"Meijers-Heijboer H, van den Ouweland A, Klijn J et al (2002) Lowpenetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations. Nat Genet 31:55\u201359","journal-title":"Nat Genet"},{"key":"10558_CR36","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s10549-006-9351-4","volume":"103","author":"C Martinez-Bouzas","year":"2007","unstructured":"Martinez-Bouzas C, Beristain E, Guerra I et al (2007) CHEK2 1100delC is present in familial breast cancer cases of the Basque Country. Breast Cancer Res Treat 103:111\u2013113","journal-title":"Breast Cancer Res Treat"},{"key":"10558_CR37","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/ng1092-132","volume":"2","author":"R Wooster","year":"1992","unstructured":"Wooster R, Mangion J, Eeles R et al (1992) A germline mutation in the androgen receptor gene in two brothers with breast cancer and Reifenstein syndrome. Nat Genet 2:132\u2013134","journal-title":"Nat Genet"},{"key":"10558_CR38","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1023\/A:1021369508561","volume":"77","author":"K Syrjakoski","year":"2003","unstructured":"Syrjakoski K, Hyytinen ER, Kuukasjarvi T et al (2003) Androgen receptor gene alterations in Finnish male breast cancer. Breast Cancer Res Treat 77:167\u2013170","journal-title":"Breast Cancer Res Treat"},{"key":"10558_CR39","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/sj.bjc.6690663","volume":"81","author":"IE Young","year":"1999","unstructured":"Young IE, Kurian KM, Annink C et al (1999) A polymorphism in the CYP17 gene is associated with male breast cancer. Br J Cancer 81:141\u2013143","journal-title":"Br J Cancer"},{"issue":"3","key":"10558_CR40","doi-asserted-by":"crossref","first-page":"200","DOI":"10.2174\/1566524022666220120123557","volume":"23","author":"SK Ray","year":"2023","unstructured":"Ray SK, Mukherjee S (2023) Interaction among noncoding RNAs, DNA damage reactions, and genomic instability in the hypoxic tumor: is it therapeutically exploitable practice? Curr Mol Med 23(3):200\u2013215","journal-title":"Curr Mol Med"},{"key":"10558_CR41","doi-asserted-by":"crossref","first-page":"R58","DOI":"10.1186\/bcr2348","volume":"11","author":"M Fassan","year":"2009","unstructured":"Fassan M, Baffa R, Palazzo J et al (2009) MicroRNA expression profiling of male breast cancer. Breast Cancer Res 11:R58","journal-title":"Breast Cancer Res"},{"key":"10558_CR42","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1200\/JCO.2007.14.5375","volume":"26","author":"HJ Burstein","year":"2008","unstructured":"Burstein HJ, Elias AD, Rugo HS et al (2008) Phase II study of sunitinib malate, an oral multitargeted tyrosine kinase inhibitor, in patients with metastatic breast cancer previously treated with an anthracycline and a taxane. J Clin Oncol 26:1810\u20131816","journal-title":"J Clin Oncol"},{"key":"10558_CR43","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1056\/NEJMoa072113","volume":"357","author":"K Miller","year":"2007","unstructured":"Miller K, Wang M, Gralow J et al (2007) Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer. N Engl J Med 357:2666\u20132676","journal-title":"N Engl J Med"},{"key":"10558_CR44","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1097\/CAD.0b013e32832b2ea0","volume":"20","author":"G Bianchi","year":"2009","unstructured":"Bianchi G, Loibl S, Zamagni C et al (2009) Phase II multicenter, uncontrolled trial of sorafenib in patients with metastatic breast cancer. Anticancer Drugs 20:616\u2013624","journal-title":"Anticancer Drugs"},{"key":"10558_CR45","doi-asserted-by":"crossref","first-page":"R68","DOI":"10.1186\/bcr2129","volume":"10","author":"S Howell","year":"2008","unstructured":"Howell S, Anderson E, Hunter T et al (2008) Prolactin receptor antagonism reduces the clonogenic capacity of breast cancer cells and potentiates doxorubicin and paclitaxel cytotoxicity. Breast Cancer Res 10:R68","journal-title":"Breast Cancer Res"},{"key":"10558_CR46","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.breast.2009.06.003","volume":"18","author":"Y Tallal","year":"2009","unstructured":"Tallal Y, Kelly Dakin H, Daniel R et al (2009) Survivin and COX-2 expression in male breast carcinoma. Breast 18:228\u2013232","journal-title":"Breast"},{"key":"10558_CR47","doi-asserted-by":"crossref","first-page":"R41","DOI":"10.1186\/bcr2328","volume":"11","author":"F Foster","year":"2009","unstructured":"Foster F, Owens T, Tanianis-Hughes J et al (2009) Targeting inhibitor of apoptosis proteins in combination with ErbB antagonists in breast cancer. Breast Cancer Res 11:R41","journal-title":"Breast Cancer Res"},{"key":"10558_CR48","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2174\/187152006776930882","volume":"6","author":"K Krysan","year":"2006","unstructured":"Krysan K, Reckamp KL, Sharma S et al (2006) The potential and rationale for COX-2 inhibitors in lung cancer. Anticancer Agents Med Chem 6:209\u2013220","journal-title":"Anticancer Agents Med Chem"},{"key":"10558_CR49","doi-asserted-by":"crossref","first-page":"e7731","DOI":"10.1371\/journal.pone.0007731","volume":"4","author":"A Gomez-Pozo","year":"2009","unstructured":"Gomez-Pozo A, Sanchez-Navarro I, Nistal M et al (2009) MALDI profiling of human lung cancer subtypes. PLoS ONE 4:e7731","journal-title":"PLoS ONE"},{"key":"10558_CR50","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1002\/ijc.21646","volume":"118","author":"C Rudlowski","year":"2006","unstructured":"Rudlowski C, Schulten H-J, Golas MM et al (2006) Comparative genomic hybridization analysis on male breast cancer. Int J Cancer 118:2455\u20132460","journal-title":"Int J Cancer"},{"key":"10558_CR51","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1086\/316907","volume":"67","author":"A Liede","year":"2000","unstructured":"Liede A, Metcalfe K, Hanna D et al (2000) Evaluation of the needs of male carriers of mutations in BRCA1 or BRCA2 who have undergone genetic counseling. Am J Hum Genet 67:1494\u20131504","journal-title":"Am J Hum Genet"},{"key":"10558_CR52","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1200\/JCO.2004.05.055","volume":"22","author":"A Liede","year":"2004","unstructured":"Liede A, Karlan BY, Narod SA (2004) Cancer risks for male carriers of germline mutations in BRCA1 or BRCA2: a review of the literature. J Clin Oncol 22:735\u2013742","journal-title":"J Clin Oncol"},{"key":"10558_CR53","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1093\/annonc\/mdh183","volume":"15","author":"A Contegiacomo","year":"2004","unstructured":"Contegiacomo A, Pensabene M, Capuano I, Tauchmanova L, Federico M, Turchetti D, Cortesi L, Marchetti P, Ricevuto E, Cianci G et al (2004) An oncologist-based model of cancer genetic counselling for hereditary breast and ovarian cancer. Ann Oncol 15:726\u2013732","journal-title":"Ann Oncol"},{"key":"10558_CR54","first-page":"180","volume":"18","author":"MB Daly","year":"2020","unstructured":"Daly MB, Pilarski R, Yurgelun MB, Berry MP, Buys SS, Dickson P, Domchek SM, Elkhanany A, Friedman S, Garber JE et al (2020) NCCN guidelines insights: genetic\/familial high-risk assessment: breast, ovarian, and pancreatic, version 1.2020. J Natl Compr Cancer Netw 18:180\u2013391","journal-title":"J Natl Compr Cancer Netw"},{"key":"10558_CR55","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1093\/jnci\/89.3.227","volume":"89","author":"DA Berry","year":"1997","unstructured":"Berry DA, Parmigiani G, Sanchez J, Schildkraut J, Winer E (1997) Probability of carrying a mutation of breast-ovarian cancer gene BRCA1 based on family history. J Natl Cancer Inst 89:227\u2013238","journal-title":"J Natl Cancer Inst"},{"key":"10558_CR56","first-page":"144","volume":"94","author":"DM Euhus","year":"2002","unstructured":"Euhus DM, Smith KC, Robinson L, Stucky A, Olopade OI, Cummings S, Garber JE, Chittenden A, Mills GB, Rieger P et al (2002) Pretest prediction of BRCA1 or BRCA2 mutation by risk counselors and the computer model BRCAPRO. J Natl Cancer Inst 94:144\u2013851","journal-title":"J Natl Cancer Inst"},{"key":"10558_CR57","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/ejhg.2010.29","volume":"18","author":"I Zanna","year":"2010","unstructured":"Zanna I, Rizzolo P, Sera F, Falchetti M, Aretini P, Giannini G, Masala G, Gulino A, Palli D, Ottini L (2010) The BRCAPRO 5.0 model is a useful tool in genetic counseling and clinical management of male breast cancer cases. Eur J Hum Genet 18:156\u2013858","journal-title":"Eur J Hum Genet"},{"key":"10558_CR58","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1634\/theoncologist.2014-0425","volume":"20","author":"ZI Mitri","year":"2015","unstructured":"Mitri ZI, Jackson M, Garby C, Song J, Giordano SH, Hortob\u00e1gyi GN, Singletary CN, Hashmi SS, Arun BK, Litton JK (2015) BRCAPRO 6.0 model validation in male patients presenting for BRCA testing. Oncologist 20:193\u2013597","journal-title":"Oncologist"},{"issue":"8","key":"10558_CR59","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.3390\/cancers14082006","volume":"14","author":"M Pensabene","year":"2022","unstructured":"Pensabene M, Von Arx C, De Laurentiis M (2022) Male breast cancer: from molecular genetics to clinical management. Cancers 14(8):2006","journal-title":"Cancers"},{"key":"10558_CR60","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/ng1947","volume":"39","author":"S Reid","year":"2007","unstructured":"Reid S, Schindler D, Hanenberg H, Barker K, Hanks S, Kalb R, Neveling K, Kelly P, Seal S, Freund M et al (2007) Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer. Nat Gen 39:162\u2013164","journal-title":"Nat Gen"},{"key":"10558_CR61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/jmg.2006.043257","volume":"44","author":"BP Alter","year":"2007","unstructured":"Alter BP, Rosenberg PS, Brody LC (2007) Clinical features associated with biallelic mutations in FANCD1\/BRCA2. J Med Genet 44:1\u20139","journal-title":"J Med Genet"},{"key":"10558_CR62","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1634\/theoncologist.10-7-471","volume":"10","author":"SH Giordano","year":"2005","unstructured":"Giordano SH (2005) A review of the diagnosis and management of male breast cancer. Oncologist 10:471\u2013479","journal-title":"Oncologist"},{"key":"10558_CR63","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1002\/cncr.21353","volume":"104","author":"WF Anderson","year":"2005","unstructured":"Anderson WF, Devesa SS (2005) In situ male breast carcinoma in the surveillance, epidemiology, and end results database of the National Cancer Institute. Cancer 104:1733\u20131741","journal-title":"Cancer"},{"key":"10558_CR64","doi-asserted-by":"crossref","first-page":"36","DOI":"10.5858\/2003-127-36-MVFB","volume":"127","author":"D Muir","year":"2003","unstructured":"Muir D, Kanthan R, Kanthan SC (2003) Male versus female breast cancers. A population-based comparative immunohistochemical analysis. Arch Pathol Lab Med 127:36\u201341","journal-title":"Arch Pathol Lab Med"},{"key":"10558_CR65","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1023\/B:BREA.0000019953.92921.7e","volume":"84","author":"C Rudlowski","year":"2004","unstructured":"Rudlowski C, Friedrichs N, Faridi A et al (2004) Her-2\/neu gene amplification and protein expression in primary male breast cancer. Breast Cancer Res Treat 84:215\u2013223","journal-title":"Breast Cancer Res Treat"},{"issue":"4","key":"10558_CR66","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1148\/rg.264055116","volume":"26","author":"L Chen","year":"2006","unstructured":"Chen L, Chantra PK, Larsen LH, Barton P, Rohitopakarn M, Zhu EQ et al (2006) Imaging characteristics of malignant lesions of the male breast. Radiographics 26(4):993\u20131006","journal-title":"Radiographics"},{"key":"10558_CR67","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/978-3-319-04831-4_29","volume-title":"Digital mammography: a holistic approach","author":"SE Garnett","year":"2015","unstructured":"Garnett SE (2015) Male Mammography. In: Hogg P, Kelly J, Mercer C (eds) Digital mammography: a holistic approach. Springer, Cham, pp 239\u2013240"},{"issue":"3","key":"10558_CR68","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S0720-048X(01)00483-1","volume":"43","author":"I Gunhan-Bilgen","year":"2002","unstructured":"Gunhan-Bilgen I, Bozkaya H, Ustun E, Memis A (2002) Male breast disease: clinical, mammographic, and ultrasonographic features. Eur J Radiol 43(3):246\u2013255","journal-title":"Eur J Radiol"},{"issue":"10","key":"10558_CR69","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1097\/00000478-200210000-00008","volume":"26","author":"F Sen","year":"2002","unstructured":"Sen F, Medeiros LJ, Lu D, Jones D, Lai R, Katz R et al (2002) Mantle cell lymphoma involving skin: cutaneous lesions may be the first manifestation of disease and tumors often have blastoid cytologic features. Am J Surg Pathol 26(10):1312\u20131318","journal-title":"Am J Surg Pathol"},{"issue":"7","key":"10558_CR70","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1148\/rg.347140081","volume":"34","author":"JM Net","year":"2014","unstructured":"Net JM, Mirpuri TM, Plaza MJ, Escobar CA, Whittington EE, Collado-Mesa F et al (2014) Resident and fellow education feature: US evaluation of axillary lymph nodes. Radiographics 34(7):1817\u20131818","journal-title":"Radiographics"},{"issue":"2","key":"10558_CR71","doi-asserted-by":"crossref","first-page":"413","DOI":"10.2214\/ajr.176.2.1760413","volume":"176","author":"WT Yang","year":"2001","unstructured":"Yang WT, Whitman GJ, Yuen EH, Tse GM, Stelling CB (2001) Sonographic features of primary breast cancer in men. AJR Am J Roentgenol 176(2):413\u2013416","journal-title":"AJR Am J Roentgenol"},{"issue":"3","key":"10558_CR72","doi-asserted-by":"crossref","first-page":"455","DOI":"10.2484\/rcr.v6i3.455","volume":"6","author":"A Shaw","year":"2011","unstructured":"Shaw A, Smith B, Howlett D (2011) Male breast carcinoma and the use of MRI. Radiol Case Rep 6(3):455","journal-title":"Radiol Case Rep"},{"key":"10558_CR73","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1002\/1097-0142(197908)44:2<748::AID-CNCR2820440248>3.0.CO;2-9","volume":"44","author":"HY Yap","year":"1979","unstructured":"Yap HY, Tashima CK, Blumenschein GR, Eckles NE (1979) Male breast cancer: a natural history study. Cancer 44:748\u2013754","journal-title":"Cancer"},{"key":"10558_CR74","first-page":"149","volume":"7","author":"G Carlsson","year":"1981","unstructured":"Carlsson G, Hafstrom L, Jonsson PE (1981) Male breast cancer. Clin Oncol 7:149\u2013155","journal-title":"Clin Oncol"},{"issue":"6","key":"10558_CR75","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1093\/annonc\/mdt025","volume":"24","author":"KJ Ruddy","year":"2013","unstructured":"Ruddy KJ, Winer EP (2013) Male breast cancer: risk factors, biology, diagnosis, treatment, and survivorship. Ann Oncol 24(6):1434\u20131443","journal-title":"Ann Oncol"},{"key":"10558_CR76","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1016\/0959-8049(95)00366-5","volume":"31A","author":"B Cutuli","year":"1995","unstructured":"Cutuli B, Lacroze M, Dilhuydy JM et al (1995) Male breast cancer: results of the treatments and prognostic factors in 397 cases. Eur J Cancer 31A:1960\u20131964","journal-title":"Eur J Cancer"},{"key":"10558_CR77","doi-asserted-by":"publisher","DOI":"10.1016\/j.clbc.2017.07.005","author":"W Chen","year":"2017","unstructured":"Chen W, Huang Y, Lewis GD, Szeja SS, Hatch SS, Farach A et al (2017) Treatment outcomes and prognostic factors in male patients with stage IV breast cancer: a population-based Study. Clin Breast Cancer. https:\/\/doi.org\/10.1016\/j.clbc.2017.07.005","journal-title":"Clin Breast Cancer"},{"issue":"3","key":"10558_CR78","doi-asserted-by":"crossref","first-page":"106","DOI":"10.5152\/tjbh.2015.2565","volume":"11","author":"KY \u015eafak","year":"2015","unstructured":"\u015eafak KY (2015) Mammography findings of male breast diseases. J Breast Health 11(3):106\u2013110","journal-title":"J Breast Health"},{"issue":"3","key":"10558_CR79","doi-asserted-by":"crossref","first-page":"W247","DOI":"10.2214\/AJR.09.3994","volume":"196","author":"E Iuanow","year":"2011","unstructured":"Iuanow E, Kettler M, Slanetz PJ (2011) Spectrum of disease in the male breast. AJR Am J Roentgenol 196(3):W247\u2013W259","journal-title":"AJR Am J Roentgenol"},{"issue":"4","key":"10558_CR80","doi-asserted-by":"crossref","first-page":"278","DOI":"10.4103\/0971-3026.57207","volume":"19","author":"MB Popli","year":"2009","unstructured":"Popli MB, Popli V, Bahl P, Solanki Y (2009) Pictorial essay: Mammography of the male breast. Indian J Radiol Imaging 19(4):278\u2013281","journal-title":"Indian J Radiol Imaging"},{"issue":"3","key":"10558_CR81","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jus.2011.06.004","volume":"14","author":"F Draghi","year":"2011","unstructured":"Draghi F, Tarantino CC, Madonia L, Ferrozzi G (2011) Ultrasonography of the male breast. J Ultrasound 14(3):122\u2013129","journal-title":"J Ultrasound"},{"key":"10558_CR82","doi-asserted-by":"crossref","first-page":"771","DOI":"10.7326\/0003-4819-117-9-771","volume":"117","author":"IA Jaiyesimi","year":"1992","unstructured":"Jaiyesimi IA, Buzdar AU, Sahin AA, Ross MA (1992) Carcinoma of the male breast. Ann Intern Med 117:771\u2013777","journal-title":"Ann Intern Med"},{"key":"10558_CR83","first-page":"275","volume":"13","author":"F Labrie","year":"1990","unstructured":"Labrie F, Dupont A, Belanger A et al (1990) Complete response to combination therapy with an LHRH agonist and flutamide in metastatic male breast cancer: a case report. Clin Invest Med 13:275\u2013278","journal-title":"Clin Invest Med"},{"key":"10558_CR84","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1002\/1097-0142(19930715)72:2<502::AID-CNCR2820720228>3.0.CO;2-1","volume":"72","author":"M Lopez","year":"1993","unstructured":"Lopez M, Natali M, Di Lauro L et al (1993) Combined treatment with buserelin and cyproterone acetate in metastatic male breast cancer. Cancer 72:502\u2013505","journal-title":"Cancer"},{"key":"10558_CR85","doi-asserted-by":"crossref","first-page":"e42","DOI":"10.1200\/JCO.2006.07.2397","volume":"24","author":"SH Giordano","year":"2006","unstructured":"Giordano SH, Hortobagyi GN (2006) Leuprolide acetate plus aromatase inhibition for male breast cancer. J Clin Oncol 24:e42\u2013e43","journal-title":"J Clin Oncol"},{"key":"10558_CR86","doi-asserted-by":"crossref","first-page":"4265","DOI":"10.1200\/JCO.2005.04.173","volume":"23","author":"M Marty","year":"2005","unstructured":"Marty M, Cognetti F, Maraninchi D et al (2005) Randomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as first-line treatment: the M77001 study group. J Clin Oncol 23:4265\u20134274","journal-title":"J Clin Oncol"},{"key":"10558_CR87","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/(SICI)1097-0142(19990201)85:3<629::AID-CNCR13>3.0.CO;2-V","volume":"85","author":"PE Goss","year":"1999","unstructured":"Goss PE, Reid C, Pintilie M et al (1999) Male breast carcinoma: a review of 229 patients who presented to the Princess Margaret Hospital during 40 years: 1955\u20131996. Cancer 85:629\u2013639","journal-title":"Cancer"},{"key":"10558_CR88","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0960-7404(93)90063-5","volume":"2","author":"DB Gough","year":"1993","unstructured":"Gough DB, Donohue JH, Evans MM et al (1993) A 50-year experience of male breast cancer: is outcome changing? Surg Oncol 2:325\u2013333","journal-title":"Surg Oncol"},{"key":"10558_CR89","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1002\/cncr.22589","volume":"109","author":"ZA Nahleh","year":"2007","unstructured":"Nahleh ZA, Srikantiah R, Safa M et al (2007) Male breast cancer in the veterans affairs population: a comparative analysis. Cancer 109:1471\u20131477","journal-title":"Cancer"},{"key":"10558_CR90","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.breast.2007.05.012","volume":"16","author":"M Golshan","year":"2007","unstructured":"Golshan M, Rusby J, Dominguez F, Smith BL (2007) Breast conservation for male breast carcinoma. Breast 16:653\u2013656","journal-title":"Breast"},{"key":"10558_CR91","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1093\/jnci\/91.4.368","volume":"91","author":"U Veronesi","year":"1999","unstructured":"Veronesi U, Paganelli G, Viale G et al (1999) Sentinel lymph node biopsy and axillary dissection in breast cancer: results in a large series. J Natl Cancer Inst 91:368\u2013373","journal-title":"J Natl Cancer Inst"},{"key":"10558_CR92","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/1477-7819-6-58","volume":"6","author":"KB Contractor","year":"2008","unstructured":"Contractor KB, Kaur K, Rodrigues GS et al (2008) Male breast cancer: is the scenario changing. World J Surg Oncol 6:58","journal-title":"World J Surg Oncol"},{"key":"10558_CR93","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.breast.2007.07.024","volume":"16","author":"C Kamila","year":"2007","unstructured":"Kamila C, Jenny B, Per H, Jonas B (2007) How to treat male breast cancer. Breast 16:147\u2013154","journal-title":"Breast"},{"key":"10558_CR94","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1093\/annonc\/mdi274","volume":"16","author":"G Macdonald","year":"2005","unstructured":"Macdonald G, Paltiel C, Olivotto IA, Tyldesley S (2005) A comparative analysis of radio therapy use and patient outcome in males and females with breast cancer. Ann Oncol 16:1442\u20131448","journal-title":"Ann Oncol"},{"key":"10558_CR95","doi-asserted-by":"crossref","first-page":"767","DOI":"10.3109\/02841869409083946","volume":"33","author":"MA Izquierdo","year":"1994","unstructured":"Izquierdo MA, Alonso C, De Andres L, Ojeda B (1994) Male breast cancer. Report of a series of 50 cases. Acta Oncol 33:767\u2013771","journal-title":"Acta Oncol"},{"key":"10558_CR96","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1002\/1097-0142(19891015)64:8<1583::AID-CNCR2820640804>3.0.CO;2-Q","volume":"64","author":"HZ Patel 2nd","year":"1989","unstructured":"Patel HZ 2nd, Buzdar AU, Hortobagyi GN (1989) Role of adjuvant chemotherapy in male breast cancer. Cancer 64:1583\u20131585","journal-title":"Cancer"},{"key":"10558_CR97","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/bjc.1992.50","volume":"65","author":"G Ribeiro","year":"1992","unstructured":"Ribeiro G, Swindell R (1992) Adjuvant tamoxifen for male breast cancer (MBC). Br J Cancer 65:252\u2013254","journal-title":"Br J Cancer"},{"key":"10558_CR98","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.ejca.2005.09.027","volume":"42","author":"R Iredale","year":"2006","unstructured":"Iredale R, Brain K, Williams B et al (2006) The experiences of men with breast cancer in the United Kingdom. Eur J Cancer 42:334\u2013341","journal-title":"Eur J Cancer"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-10558-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-025-10558-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-10558-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T16:26:18Z","timestamp":1766852778000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-025-10558-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,13]]},"references-count":98,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["10558"],"URL":"https:\/\/doi.org\/10.1007\/s11033-025-10558-4","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"type":"print","value":"0301-4851"},{"type":"electronic","value":"1573-4978"}],"subject":[],"published":{"date-parts":[[2025,5,13]]},"assertion":[{"value":"16 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"452"}}